Details of the Drug Formulaction

General Information of Drug Formulation (ID: F08017)

• Formulation Name: Fenofibrate 30 mg capsule
• Company: Lupin Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Fenofibrate	(DMFKXDY)	Coronary atherosclerosis		Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
FD&C blue no. 2	(E00446)	2723854	Colorant
Ferric hydroxide oxide yellow	(E00539)	23320441	Colorant
Ferrosoferric oxide	(E00231)	14789	Colorant
Potassium hydroxide	(E00233)	14797	Alkalizing agent
Propylene glycol	(E00040)	1030	Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Quinoline yellow WS	(E00309)	24671	Colorant
Saccharose	(E00091)	5988	Binding agent; Coating agent; Cryoprotectant; Diluent; Flavoring agent; Suspending agent; Viscosity-controlling agent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Soybean lecithin	(E00637)	Not Available	Other agent
Sulfur dioxide	(E00046)	1119	Antioxidant
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent